Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study.

Rungroj KrittayaphongArjbordin WinijkulKomsing MethavigulWattana WongtheptienChaiyasith WongvipapornTreechada WisaratapongRapeephon Kunjara-Na-AyudhyaSmonporn BoonyaratvejChulalak KomoltriPontawee KaewcomdeeAhthit YindeengamPiyamitr Sritaranull null

Published in: BMC cardiovascular disorders (2018)

Anticoagulation therapy was prescribed in 75.3% of patients with NVAF. Among those receiving anticoagulant, 90.9% used warfarin and 9.1% used NOACs. The use of NOACs increased over time.

Keyphrases

atrial fibrillation
oral anticoagulants
left atrial
catheter ablation
direct oral anticoagulants
left atrial appendage
heart failure
percutaneous coronary intervention
venous thromboembolism
acute coronary syndrome
left ventricular
coronary artery disease
cell therapy
bone marrow
smoking cessation